{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
{{#each product.specData:i}}
{{name}}: {{value}}
{{#i!=(product.specData.length-1)}}
{{/end}}
{{/each}}
{{{product.idpText}}}
... ProGRP (Pro-Gastrin-Releasing Peptide) is the recommended assay to distinguish SCLC (Small Cell Lung Cancer) from NSCLC (Non Small Cell Lung Cancer) because of their ...
... .com/kl-6 (opens in a new window). CE marked Lumipulse® G KL-6 Immunoreaction Cartridges Product number 233207 3 × 14 Tests
... Selection of Patients Who Need Targeted Anti-Cancer Therapy" - Identification of NSCLC (Non-small Cell Lung Cancer) patients for EGFR Tyrosine Kinase Inhibitors (TKIs) treatment - Companion ...
... for both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). But that’s just the beginning. The panel is modular, allowing you to add focused content ...
Non-small cell lung cancer (NSCLC) comprises approximately 85% of all lung cancers. Somatic mutations in the epidermal growth factor receptor tyrosine kinase (EGFR-TK) ...
Designed to identify the resistance mutation T790M in the EGFR gene in plasma-derived, circulating cell-free DNA from NSCLC patients, this assay allows the selection of patients eligible for an alternative EGFR-TK inhibitor therapy ...
... and analyze mRNA ALK gene fusion events in formalin-fixed, paraffin-embedded (FFPE) lung tumor specimens from patients previously diagnosed with non-small cell lung cancer (NSCLC). ...
The QuantideX® NGS RNA Lung Cancer Kit* is a clinical research tool enabling the simultaneous assessment of fusions, exon skipping, and other expression targets frequently observed in ...
Lung cancer is the most frequently diagnosed cancer and the leading cause of cancer mortality worldwide. Patients may suffer from one of two cancer types: ...
Please specify:
Help us improve:
remaining